Paloma Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,885
| Closed | -$528K | – | 141 |
|
|
2025
Q1 | $528K | Buy |
+5,885
| New | +$549K | 0.07% | 93 |
|
|
2024
Q4 | – | Sell |
-4,017
| Closed | -$456K | – | 792 |
|
|
2024
Q3 | $456K | Sell |
4,017
-44,963
| -92% | -$5.34M | 0.01% | 653 |
|
|
2024
Q2 | $6.06M | Buy |
48,980
+27,150
| +124% | +$3.5M | 0.17% | 84 |
|
|
2024
Q1 | $2.88M | Buy |
+21,830
| New | +$2.69M | 0.15% | 168 |
|
|
2022
Q4 | – | Sell |
-200
| Closed | -$17K | – | 1075 |
|
|
2022
Q3 | $17K | Sell |
200
-27,200
| -99% | -$2.43M | ﹤0.01% | 936 |
|
|
2022
Q2 | $2.5M | Sell |
27,400
-6,092
| -18% | -$540K | 0.09% | 222 |
|
|
2022
Q1 | $2.75M | Sell |
33,492
-161,833
| -83% | -$12.8M | 0.08% | 168 |
|
|
2021
Q4 | $15M | Buy |
195,325
+102,069
| +109% | +$8.13M | 0.22% | 49 |
|
|
2021
Q3 | $7M | Buy |
+93,256
| New | +$7.09M | 0.17% | 74 |
|
|
2021
Q2 | – | Sell |
-107,294
| Closed | -$7.98M | – | 2085 |
|
|
2021
Q1 | $7.89M | Buy |
107,294
+99,224
| +1,230% | +$7.32M | 0.17% | 100 |
|
|
2020
Q4 | $630K | Sell |
8,070
-47,296
| -85% | -$3.62M | 0.02% | 782 |
|
|
2020
Q3 | $4.38M | Sell |
55,366
-15,872
| -22% | -$1.24M | 0.11% | 172 |
|
|
2020
Q2 | $5.26M | Buy |
71,238
+44,405
| +165% | +$3.34M | 0.09% | 278 |
|
|
2020
Q1 | $1.97M | Sell |
26,833
-56,429
| -68% | -$4.43M | 0.11% | 135 |
|
|
2019
Q4 | $7.23M | Sell |
83,262
-100,924
| -55% | -$8.29M | 0.11% | 150 |
|
|
2019
Q3 | $14.8M | Buy |
184,186
+146,258
| +386% | +$11.7M | 0.31% | 45 |
|
|
2019
Q2 | $3.04M | Sell |
37,928
-53,879
| -59% | -$4.13M | 0.05% | 287 |
|
|
2019
Q1 | $7.29M | Sell |
91,807
-314,010
| -77% | -$23.5M | 0.18% | 99 |
|
|
2018
Q4 | $29.6M | Buy |
405,817
+147,274
| +57% | +$10.4M | 0.9% | 19 |
|
|
2018
Q3 | $17.5M | Buy |
258,543
+35,267
| +16% | +$2.25M | 0.32% | 49 |
|
|
2018
Q2 | $12.9M | Buy |
223,276
+193,622
| +653% | +$10.9M | 0.24% | 70 |
|
|
2018
Q1 | $1.54M | Buy |
29,654
+2,166
| +8% | +$117K | 0.02% | 733 |
|
|
2017
Q4 | $1.48M | Sell |
27,488
-40,194
| -59% | -$2.23M | 0.02% | 831 |
|
|
2017
Q3 | $4.13M | Sell |
67,682
-31,572
| -32% | -$1.91M | 0.06% | 347 |
|
|
2017
Q2 | $6.07M | Buy |
99,254
+71,390
| +256% | +$4.35M | 0.07% | 272 |
|
|
2017
Q1 | $1.69M | Sell |
27,864
-138,747
| -83% | -$8.42M | 0.02% | 900 |
|
|
2016
Q4 | $9.36M | Buy |
166,611
+93,019
| +126% | +$5.44M | 0.09% | 132 |
|
|
2016
Q3 | $4.38M | Sell |
73,592
-26,035
| -26% | -$1.52M | 0.05% | 232 |
|
|
2016
Q2 | $5.48M | Buy |
99,627
+54,318
| +120% | +$2.89M | 0.06% | 237 |
|
|
2016
Q1 | $2.29M | Sell |
45,309
-23,355
| -34% | -$1.14M | 0.04% | 428 |
|
|
2015
Q4 | $3.46M | Buy |
68,664
+44,330
| +182% | +$2.24M | 0.09% | 186 |
|
|
2015
Q3 | $1.15M | Sell |
24,334
-227,275
| -90% | -$12.1M | 0.03% | 570 |
|
|
2015
Q2 | $13.7M | Buy |
251,609
+142,163
| +130% | +$7.97M | 0.26% | 81 |
|
|
2015
Q1 | $6M | Sell |
109,446
-85,861
| -44% | -$4.86M | 0.17% | 103 |
|
|
2014
Q4 | $10.6M | Sell |
195,307
-6,213
| -3% | -$346K | 0.45% | 40 |
|
|
2014
Q3 | $11.4M | Buy |
201,520
+9,846
| +5% | +$553K | 0.52% | 39 |
|
|
2014
Q2 | $10.6M | Buy |
+191,674
| New | +$10.5M | 0.43% | 46 |
|
|
2014
Q1 | – | Sell |
-6,802
| Closed | -$325K | – | 890 |
|
|
2013
Q4 | $325K | Sell |
6,802
-217,889
| -97% | -$9.96M | 0.02% | 770 |
|
|
2013
Q3 | $10.2M | Buy |
224,691
+214,316
| +2,066% | +$9.79M | 0.4% | 31 |
|
|
2013
Q2 | $460K | Buy |
+10,375
| New | +$463K | 0.03% | 514 |
|
Other funds holding MRK
Paloma Partners's MRK Position: Q2 2025 in Review
Paloma Partners sold out of Merck (MRK) in Q2 2025, closing a stake of 5,885 shares — an estimated $528K sold.
Paloma Partners first reported a position in MRK in Q2 2013 and held it in 40 quarters. The position peaked at $29.6M in Q4 2018. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Paloma Partners reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
- Paloma Partners sold 5,885 Merck shares in Q2 2025, an estimated $528K.
- Paloma Partners first reported a position in Merck in Q2 2013 and held it in 40 quarters.
- Paloma Partners's Merck position peaked at $29.6M in Q4 2018.
- 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.